Local Infiltration Analgesia (LIA) and Continuous Wound Infusion (CWI) (also called continuous wound infiltration) are both techniques used in multimodal postoperative pain management to provide analgesia by delivering local anesthetics directly to the surgical site, reducing the need for opioids and their side effects (e.g., nausea, sedation, respiratory depression).Local Infiltration Analgesia (LIA)LIA is a surgeon-administered technique involving a single-shot (or sometimes repeated) injection of a high-volume, diluted mixture of long-acting local anesthetic (typically ropivacaine or bupivacaine) into the tissues around the surgical field, including periarticular, subcutaneous, and deeper layers.Common adjuvants \u2014 Often include ketorolac (NSAID), epinephrine (to prolong effect and reduce bleeding), and sometimes corticosteroids or morphine.<\/p>\n
Typical use \u2014 Primarily popularized for total knee arthroplasty (TKA) and total hip arthroplasty (THA), but applied in other procedures.<\/p>\n
Technique \u2014 Performed intraoperatively, often toward the end of surgery. A large volume (e.g., 150\u2013170 mL of dilute ropivacaine ~2 mg\/mL, plus adjuvants) infiltrates multiple layers systematically.<\/p>\n
Advantages \u2014 Provides immediate, effective short- to medium-term analgesia (hours to ~1\u20132 days), improves early mobilization, and reduces opioid consumption.<\/p>\n
Limitations \u2014 Analgesia duration is limited unless supplemented (e.g., with catheters for top-ups).<\/p>\n
Continuous Wound Infusion (CWI)CWI involves placing a multi-holed catheter into or near the surgical wound at the end of the procedure, connected to a pump (e.g., elastomeric pump like ON-Q) for continuous or intermittent delivery of local anesthetic over days.Common agents \u2014 Ropivacaine (e.g., 0.2\u20130.5%) or levobupivacaine, infused at rates like 2 mL\/h for 48\u201372 hours or longer.<\/p>\n
Typical use \u2014 Broadly applied in abdominal surgeries (e.g., laparotomy, colorectal, cesarean, hepatectomy), thoracic procedures, orthopedic wounds, and more.<\/p>\n
Technique \u2014 Surgeon inserts the catheter (subcutaneous, preperitoneal, or wound layers) before closure. Delivery modes include continuous infusion, patient-controlled boluses, or intermittent.<\/p>\n
Advantages \u2014 Provides prolonged analgesia (days), opioid-sparing effects, reduced pain at rest\/movement, faster bowel recovery in abdominal cases, and fewer side effects (e.g., lower nausea\/vomiting, hypotension risk in some comparisons).<\/p>\n
Safety \u2014 Generally low risk of infection, no major increase in wound complications; effective alternative to epidural or IV PCA in many settings.<\/p>\n
<\/p>\n
Key Similarities and DifferencesBoth are part of multimodal analgesia (combined with oral\/IV NSAIDs, acetaminophen, etc.) and target peripheral nociception to minimize systemic opioids.Aspect<\/p>\n
Local Infiltration Analgesia (LIA)<\/p>\n
Continuous Wound Infusion (CWI)<\/p>\n
Delivery<\/p>\n
Single high-volume injection (\u00b1 adjuvants)<\/p>\n
Continuous\/low-rate infusion via catheter<\/p>\n
Duration<\/p>\n
Short- to medium-term (hours to 1\u20132 days)<\/p>\n
Prolonged (1\u2013several days)<\/p>\n
Primary Surgeries<\/p>\n
Orthopedic (esp. knee\/hip arthroplasty)<\/p>\n
Abdominal, thoracic, cesarean, general surgery<\/p>\n
Catheter Use<\/p>\n
Usually none (or for top-ups in some protocols)<\/p>\n
Required (multi-holed catheter + pump)<\/p>\n
Opioid-Sparing<\/p>\n
Yes, significant<\/p>\n
Yes, often more sustained<\/p>\n
Efficacy<\/p>\n
Excellent for early pain\/mobilization in joints<\/p>\n
Good for extended pain control; variable by site<\/p>\n
Complexity<\/p>\n
Simpler, no device needed post-op<\/p>\n
Requires pump management, catheter removal<\/p>\n
<\/p>\n
LIA is sometimes considered a subset or initial step of wound infiltration techniques, while CWI extends it for longer duration. In some contexts (e.g., orthopedic), LIA may be combined with CWI for enhanced effect.Both are safe and effective in reducing postoperative pain and opioid use, with evidence from meta-analyses and RCTs supporting their role in enhanced recovery protocols (ERAS). Choice depends on surgery type, expected pain duration, and institutional resources. Consult current guidelines or an anesthesiologist for specific applications.<\/p>\n
You may Also Like<\/p>\n